Novel cardiovascular protective effects of RhoA signaling and its therapeutic implications

Biochem Pharmacol. 2023 Dec:218:115899. doi: 10.1016/j.bcp.2023.115899. Epub 2023 Oct 30.

Abstract

Ras homolog gene family member A (RhoA) belongs to the Rho GTPase superfamily, which was first studied in cancers as one of the essential regulators controlling cellular function. RhoA has long attracted attention as a key molecule involved in cell signaling and gene transcription, through which it affects cellular processes. A series of studies have demonstrated that RhoA plays crucial roles under both physiological states and pathological conditions in cardiovascular diseases. RhoA has been identified as an important regulator in cardiac remodeling by regulating actin stress fiber dynamics and cytoskeleton formation. However, its underlying mechanisms remain poorly understood, preventing definitive conclusions being drawn about its protective role in the cardiovascular system. In this review, we outline the characteristics of RhoA and its related signaling molecules, and present an overview of RhoA classical function and the corresponding cellular responses of RhoA under physiological and pathological conditions. Overall, we provide an update on the novel signaling under RhoA in the cardiovascular system and its potential clinical and therapeutic targets in cardiovascular medicine.

Keywords: Aging; Endothelium; Heart; Small GTPase; Vascular smooth muscle.

Publication types

  • Review

MeSH terms

  • Actins / metabolism
  • Cardiovascular System* / metabolism
  • Humans
  • Signal Transduction / physiology
  • rho GTP-Binding Proteins
  • rho-Associated Kinases* / metabolism
  • rhoA GTP-Binding Protein / genetics
  • rhoA GTP-Binding Protein / metabolism

Substances

  • Actins
  • rho GTP-Binding Proteins
  • rho-Associated Kinases
  • rhoA GTP-Binding Protein
  • RHOA protein, human